Maximilian Fleischmann

820 total citations
31 papers, 271 citations indexed

About

Maximilian Fleischmann is a scholar working on Oncology, Surgery and Hematology. According to data from OpenAlex, Maximilian Fleischmann has authored 31 papers receiving a total of 271 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 11 papers in Surgery and 10 papers in Hematology. Recurrent topics in Maximilian Fleischmann's work include Acute Myeloid Leukemia Research (9 papers), Colorectal and Anal Carcinomas (7 papers) and Colorectal Cancer Surgical Treatments (6 papers). Maximilian Fleischmann is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), Colorectal and Anal Carcinomas (7 papers) and Colorectal Cancer Surgical Treatments (6 papers). Maximilian Fleischmann collaborates with scholars based in Germany, Switzerland and United Kingdom. Maximilian Fleischmann's co-authors include Sebastian Scholl, Ulf Schnetzke, Andreas Hochhaus, Florian H. Heidel, Emmanouil Fokas, Claus Rödel, Franz Rödel, Markus Diefenhardt, Claus Rödel and Nikolaos Tselis and has published in prestigious journals such as Scientific Reports, Annals of Oncology and Cells.

In The Last Decade

Maximilian Fleischmann

29 papers receiving 268 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maximilian Fleischmann Germany 9 111 109 96 32 32 31 271
Christopher Strouse United States 9 159 1.4× 129 1.2× 94 1.0× 25 0.8× 21 0.7× 49 319
Shaoyan Hu China 10 124 1.1× 176 1.6× 61 0.6× 31 1.0× 41 1.3× 77 325
Joanna Zawitkowska Poland 11 121 1.1× 126 1.2× 115 1.2× 29 0.9× 32 1.0× 61 386
Hady Ghanem Lebanon 11 135 1.2× 90 0.8× 57 0.6× 62 1.9× 22 0.7× 33 270
Fauzia Ullah United States 10 58 0.5× 66 0.6× 118 1.2× 18 0.6× 12 0.4× 26 210
Fabio Guolo Italy 10 112 1.0× 78 0.7× 127 1.3× 36 1.1× 19 0.6× 46 306
Nicholas D’Cunha United States 9 49 0.4× 85 0.8× 151 1.6× 23 0.7× 37 1.2× 32 282
Arne Trummer Germany 9 108 1.0× 116 1.1× 34 0.4× 25 0.8× 28 0.9× 28 247
Rossana Putzulu Italy 9 133 1.2× 157 1.4× 51 0.5× 42 1.3× 13 0.4× 26 295
Christin B. DeStefano United States 10 147 1.3× 99 0.9× 138 1.4× 34 1.1× 7 0.2× 30 292

Countries citing papers authored by Maximilian Fleischmann

Since Specialization
Citations

This map shows the geographic impact of Maximilian Fleischmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maximilian Fleischmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maximilian Fleischmann more than expected).

Fields of papers citing papers by Maximilian Fleischmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maximilian Fleischmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maximilian Fleischmann. The network helps show where Maximilian Fleischmann may publish in the future.

Co-authorship network of co-authors of Maximilian Fleischmann

This figure shows the co-authorship network connecting the top 25 collaborators of Maximilian Fleischmann. A scholar is included among the top collaborators of Maximilian Fleischmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maximilian Fleischmann. Maximilian Fleischmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ernst, Benjamin Philipp, Andrew Blaikie, Tom Kelsey, et al.. (2025). Assessment of decision-making with locally run and web-based large language models versus human board recommendations in otorhinolaryngology, head and neck surgery. European Archives of Oto-Rhino-Laryngology. 282(3). 1593–1607. 4 indexed citations
2.
Fleischmann, Maximilian, A Kristen, Ria Winkelmann, et al.. (2025). Neoadjuvant chemoradiation for patients with resectable locally advanced oral cavity squamous cell carcinoma: Results of the prospective INVERT clinical trial. Oral Oncology. 164. 107252–107252.
3.
Achenbach, Janosch, Markus Diefenhardt, Maximilian Fleischmann, et al.. (2025). Advantages of 3D printed patient-individual moulds in brachytherapy for facial skin cancer. Strahlentherapie und Onkologie. 201(9). 940–952.
4.
Fleischmann, Maximilian, Madlen Jentzsch, Annamaria Brioli, et al.. (2024). Azacitidine in combination with shortened venetoclax treatment cycles in patients with acute myeloid leukemia. Annals of Hematology. 104(1). 285–294. 2 indexed citations
5.
Martin, Daniel, Franz Rödel, Stephanie Hehlgans, et al.. (2024). Inflammatory pathways confer resistance to chemoradiotherapy in anal squamous cell carcinoma. npj Precision Oncology. 8(1). 93–93. 4 indexed citations
6.
7.
Fleischmann, Maximilian, Hendrik Dapper, Markus Diefenhardt, et al.. (2024). Perkutane Strahlentherapie kombiniert mit endorektaler Brachytherapie zum Organerhalt bei älteren/gebrechlichen Patienten mit Rektumkarzinom – die ACO/ARO/AIO-22-Studie. 30(2). 129–132. 1 indexed citations
8.
Diefenhardt, Markus, Daniel Martín, Ralf‐Dieter Hofheinz, et al.. (2024). Persistent Lymph Node Metastases After Neoadjuvant Chemoradiotherapy for Rectal Cancer. JAMA Network Open. 7(9). e2432927–e2432927. 2 indexed citations
9.
Motisi, Laura, Andrea Bink, Martina A. Broglie, et al.. (2024). MRI-based radiomics for predicting histology in malignant salivary gland tumors: methodology and “proof of principle”. Scientific Reports. 14(1). 9945–9945. 2 indexed citations
10.
Tamaskovics, Bálint, Markus Hecht, Philipp Schubert, et al.. (2023). 944TiP Randomized phase II study of immune stimulation with pembrolizumab and radiotherapy of recurrent and/or metastatic head and neck squamous cell carcinoma : The IMPORTANCE trial. Annals of Oncology. 34. S593–S593. 1 indexed citations
11.
Fleischmann, Maximilian & Claus Rödel. (2023). Vergleich der radikalen Zystektomie mit der trimodalen Therapie beim muskelinvasiven Harnblasenkarzinom. Strahlentherapie und Onkologie. 199(9). 871–873. 1 indexed citations
12.
Diefenhardt, Markus, Daniel Martin, Maximilian Fleischmann, et al.. (2023). Overall Survival After Treatment Failure Among Patients With Rectal Cancer. JAMA Network Open. 6(10). e2340256–e2340256. 6 indexed citations
13.
Diefenhardt, Markus, Daniel Martin, Ethan B. Ludmir, et al.. (2022). Development and Validation of a Predictive Model for Toxicity of Neoadjuvant Chemoradiotherapy in Rectal Cancer in the CAO/ARO/AIO-04 Phase III Trial. Cancers. 14(18). 4425–4425. 4 indexed citations
14.
Fleischmann, Maximilian, Sebastian Scholl, Inken Hilgendorf, et al.. (2022). Clinical experience with venetoclax in patients with newly diagnosed, relapsed, or refractory acute myeloid leukemia. Journal of Cancer Research and Clinical Oncology. 148(11). 3191–3202. 15 indexed citations
15.
Fleischmann, Maximilian, Markus Diefenhardt, Adele M. Nicolas, et al.. (2022). ACO/ARO/AIO-21 - Capecitabine-based chemoradiotherapy in combination with the IL-1 receptor antagonist anakinra for rectal cancer Patients: A phase I trial of the German rectal cancer study group. Clinical and Translational Radiation Oncology. 34. 99–106. 17 indexed citations
16.
Fleischmann, Maximilian, Ulla Ramm, Gesine Bug, et al.. (2022). Twenty years of experience of a tertiary cancer center in total body irradiation with focus on oncological outcome and secondary malignancies. Strahlentherapie und Onkologie. 198(6). 547–557. 7 indexed citations
17.
Schnetzke, Ulf, et al.. (2022). Impact of treatment intensity on infectious complications in patients with acute myeloid leukemia. Journal of Cancer Research and Clinical Oncology. 149(4). 1569–1583. 7 indexed citations
18.
Scholl, Sebastian, Inken Hilgendorf, Maximilian Fleischmann, et al.. (2021). Outcome of patients with relapsed or refractory acute myeloid leukemia treated with Mito-FLAG salvage chemotherapy. Journal of Cancer Research and Clinical Oncology. 148(9). 2539–2548. 1 indexed citations
19.
Fleischmann, Maximilian, Markus Glatzer, Claus Rödel, & Nikolaos Tselis. (2021). Radioimmunotherapy: future prospects from the perspective of brachytherapy. Journal of Contemporary Brachytherapy. 13(4). 458–467. 6 indexed citations
20.
Fleischmann, Maximilian, Ulf Schnetzke, Herbert G. Sayer, et al.. (2016). Outcome of FLT3-ITD-positive acute myeloid leukemia: impact of allogeneic stem cell transplantation and tyrosine kinase inhibitor treatment. Journal of Cancer Research and Clinical Oncology. 143(2). 337–345. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher Strouse Breakdown of academic impact, for papers by Shaoyan Hu Breakdown of academic impact, for papers by Joanna Zawitkowska Breakdown of academic impact, for papers by Hady Ghanem Breakdown of academic impact, for papers by Fauzia Ullah Breakdown of academic impact, for papers by Fabio Guolo Breakdown of academic impact, for papers by Nicholas D’Cunha Breakdown of academic impact, for papers by Arne Trummer Breakdown of academic impact, for papers by Rossana Putzulu Breakdown of academic impact, for papers by Christin B. DeStefano
Rankless by CCL
2026